pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

178 catalysts · 3,288 8k filing · 1,642 grant · 1,000 device adverse event · 755 approval · 597 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: device recall×from 2026-02-10×clear all
type
  • 8k filing3,288
  • grant1,642
  • device adverse event1,000
  • approval755
  • device 510k597
  • earnings584
device pma
455
  • device recall178
  • phase 2 completion172
  • recall162
  • therapy area

    no tagged catalysts yet

    Week of Feb 9, 2026

    49
    ›Feb 10, 2026device recall185d agoOrthalign, Inc device recall (Cls II)

    Drill Plate, Ortho Dev. Trimax - Pegged, PREF Size 1 -5 REF:402566 component Lantern Knee System — Reason: Drill plates manufactured out of specification can result in a bone cut in excess 00800"(2.8448mm) — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 10, 2026device recall185d agoOrthalign, Inc device recall (Cls II)

    Drill Plate, Ortho Dev. Trimax - Pegged, PREF Size 6-7 REF:402567 component Lantern Knee System — Reason: Drill plates manufactured out of specification can result in a bone cut in excess 00800"(2.8448mm) — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 10, 2026device recall185d agoLeMaitre Vascular, Inc. device recall (Cls II)LEMAITRE VASCULAR INC

    Artegraft Vascular Graft; REF#: AG740; — Reason: Labeling mix-up resulting in the incorrect lot outer packaging of product. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 10, 2026device recall185d agoBoston Scientific Corporation device recall (Cls II)BOSTON SCIENTIFIC CORP

    EndoVive Safety PEG Kit; Outer Box Material Number (UPN): M00509001; Inner Box Material Number (UPN): M00509000; — Reason: Recall of kits which utilized ChloraPrep Triple Swabsticks from BD. Open or compromised seals on the sterile swabstick packaging, which could result in loss of sterility or drying of the antiseptic solution. This component is placed outside of the sterile barrier of the tray manufactured by Boston Scientific, which contains the majority of the kit components. As such, inclusion of the affected ChloraPrep Triple Swabsticks does not degrade the integrity of the other components within the PEG kit. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 10, 2026device recall185d agoMedline Industries, LP device recall (Cls II)

    Puracol and Puracol Plus Collagen Wound Dressings: MSC8522 DRESSING,COLLAGEN,PURACOL,STRL,2" X 2" MSC8622EP DRESSING,COLLAGEN,PURACOL PLUS, 2X2.2" — Reason: Elevated endotoxin levels identified in affected lots. Issue may elicit strong inflammatory response if used, including local tissue irritation, delayed wound healing, or systemic effects such as fever and hypotension. In severe cases, septic shock may result. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Wrap Aprons. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Leg Wraps. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Half Aprons. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Vest — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Demi Half Aprons. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoCareFusion 303, Inc. device recall (Cls II)

    BD Alaris" System with Guardrails" Suite MX with Point of Care Unit — Reason: Due to product labeling not indicating which Transport Layer Security (TLS) version that must be enabled on hospital network to ensure secure Wi-Fi communication with Point-of-Care Units — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Kilt Blockers. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoWaldemar Link GmbH & Co. KG (Mfg Site) device recall (Cls II)

    Embrace Drill Tower, Wedged (25mm); Item Number: 645-081/62; — Reason: The surgical technique for the Embrace Shoulder Instruments - Drill Tower has mixed-up article numbers in the overview of the instruments. However, the individual surgical steps described in the surgical technique are correct. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Protective Sleeves. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Frontal Aprons — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Blockers. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoWaldemar Link GmbH & Co. KG (Mfg Site) device recall (Cls II)

    Embrace Drill Tower, Standard/Lateral (25mm); Item Number: 645-081/63; — Reason: The surgical technique for the Embrace Shoulder Instruments - Drill Tower has mixed-up article numbers in the overview of the instruments. However, the individual surgical steps described in the surgical technique are correct. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Thyroid Shield. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Caps. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, Kilt — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 11, 2026device recall184d agoBurlington Medical, LLC device recall (Cls II)

    Burlington Medical, BAT (Breast, Axilla and Thyroid) Coverage. — Reason: Potential for attenuation degradation over time, decreasing the lifespan. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 12, 2026device recall183d agoErbe USA Inc device recall (Cls I)

    Flexible Cryoprobe (OD 1.1mm, L1.15mm) w/ oversheath (OD2.6mm, L817mm) REF: 20402-401 STERILEEO. For surgical use — Reason: Probes may rupture/burst during activation — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 12, 2026device recall183d agoErbe USA Inc device recall (Cls I)

    Flexible Cryoprobe (OD 2.4mm, L1.15mm) REF: 20402-411. For surgical use — Reason: Probes may rupture/burst during activation — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 12, 2026device recall183d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Endoscope Suction Valve - MAJ-1443. Model Number: MAJ-1443. — Reason: The MAJ-1443 and MAJ-1444 are no longer reprocessing compatible with the OER-Pro and OER-Elite automated endoscope reprocessors. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 12, 2026device recall183d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Endoscope Reprocessor OER-Pro. Model Number: N3058140. — Reason: The MAJ-1443 and MAJ-1444 are no longer reprocessing compatible with the OER-Pro and OER-Elite automated endoscope reprocessors. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 12, 2026device recall183d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Endoscope Reprocessor OER-Elite. Model Number: N5789340. — Reason: The MAJ-1443 and MAJ-1444 are no longer reprocessing compatible with the OER-Pro and OER-Elite automated endoscope reprocessors. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 12, 2026device recall183d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Endoscope Air/Water Valve - MAJ-1444. Model Number: MAJ-1444. — Reason: The MAJ-1443 and MAJ-1444 are no longer reprocessing compatible with the OER-Pro and OER-Elite automated endoscope reprocessors. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 12, 2026device recall183d agoErbe USA Inc device recall (Cls I)

    Flexible Cryoprobe (OD 1.7mm, L1.15mm) REF: 20402-410. For surgical use — Reason: Probes may rupture/burst during activation — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 720G Insulin Pump (MMT-1809, MMT-1810, MMT-1859, MMT-1860, MMT-1867) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    Paradigm REAL-Time Veo Insulin Pump (MMT-554, MMT-754) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 620G Insulin Pump (MMT-1750) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMerit Medical Systems, Inc. device recall (Cls I)MERIT MEDICAL SYSTEMS INC

    CentrosFLO Hemodialysis Catheters, REF: CENFP15K/A, CENFP15K/B, CENFP17K/A, CENFP19K/A, CENFP23K/A, CENFP27K/A, CENFP31K/A, CENFT15K, CENFT15K/D, CENFT17K, CENFT17K/A, CENFT17K/D, CENFT19K, CENFT19K/A, CENFT19K/B, CENFT19K/D, CENFT23K, CENFT23K/A, CENFT23K/B, CENFT23K/D, CENFT27K, CENFT27K/A, CENFT27K/B, CENFT27K/D, CENFT31K, CENFT31K/A, CENFT31K/B, CENFT31K/D — Reason: 16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, loss of vessel for future vascular access. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    Paradigm Insulin Pump (MMT-712, MMT-715) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMerit Medical Systems, Inc. device recall (Cls I)MERIT MEDICAL SYSTEMS INC

    ProGuide Chronic Dialysis Catheters, REF: DC01455550/C, DC21452419/C, DC21452419-NE5/C, DC21452823-NE5/C, DC21454035/C, DC21455550/C — Reason: 16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, loss of vessel for future vascular access. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 740G Insulin Pump (MMT-1811, MMT-1812, MMT-1861, MMT-1862) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    Paradigm REAL-Time Revel Insulin Pump (MMT-523, MMT-723) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedline Industries, LP device recall (Cls II)

    Medline Kits containing ENFIT G-TUBE CONNECTOR 1. SKU DYKM2720 G/J TUBE CARE KIT 2. SKU ENFITDISCKIT ENFIT DISCHARGE KIT — Reason: Connectors were not manufactured to required dimensional specifications and may not form a proper seal with ENFit-style devices, which could lead to leakage. Leakage may result in delayed care and fluid loss. Additional consequences may also occur if user over-tightens the connector to stop the leakage, including additional clinical intervention, risk of infection, patient discomfort, and prolonged recovery process. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMerit Medical Systems, Inc. device recall (Cls I)MERIT MEDICAL SYSTEMS INC

    16F Dual Valved Splittable Sheath Introducer (bulk, non-sterile), REF: FCL-174-00/B — Reason: 16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, loss of vessel for future vascular access. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedline Industries, LP device recall (Cls II)

    ENFIT G-TUBE CONNECTOR, MEDLINE Item No. ENFIT1010GC — Reason: Connectors were not manufactured to required dimensional specifications and may not form a proper seal with ENFit-style devices, which could lead to leakage. Leakage may result in delayed care and fluid loss. Additional consequences may also occur if user over-tightens the connector to stop the leakage, including additional clinical intervention, risk of infection, patient discomfort, and prolonged recovery process. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMerit Medical Systems, Inc. device recall (Cls I)MERIT MEDICAL SYSTEMS INC

    BioFlo DuraMax Catheter, REF: H965103028011/A, H965103028021/A, H965103028021/EU, H965103028031/A, H965103028031/EU, H965103028041/A, H965103028041/EU, H965103028051/A, H965103028051/EU, H965103028061/A, H965103028061/EU, H965103028070/A, H965103028070/EU, H965103028080/A, H965103028080/EU, H965103028090/A, H965103028090/EU, H965103028161/A, H965103028181/A, H965103028191/A, H965103028191/EU, H965103028201/A, H965103028211/A, H965103028220/A, H965103028230/A, H965103028240/A, H965103038181/A — Reason: 16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, loss of vessel for future vascular access. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 530G Insulin Pump (MMT-551, MMT-751) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 780G Insulin Pump (MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, MMT-1896) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 640G Insulin Pump (MMT-1711, MMT-1712, MMT-1751, MMT-1752) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 630G Insulin Pump (MMT-1714, MMT-1715, MMT-1754, MMT-1755) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMerit Medical Systems, Inc. device recall (Cls I)MERIT MEDICAL SYSTEMS INC

    DuraMax Chronic Hemodialysis Catheter, REF: H787103028015/A, H787103028025/A, H787103028031/A, H787103028035/A, H787103028041/A, H787103028045/A, H787103028051/A, H787103028055/A, H787103028061/A, H787103028075/A, H787103028085/A, H787103028095/A, H787103028165/A, H787103028181/A, H787103028185/A, H787103028191/A, H787103028195/A, H787103028205/A, H787103028215/A, H787103028225/A, H787103028235/A — Reason: 16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, loss of vessel for future vascular access. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 770G Insulin Pump (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 700G Insulin Pump (MMT-1801, MMT-1805, MMT-1850, MMT-1851) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall182d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 670G Insulin Pump (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗

    Week of Feb 16, 2026

    1
    ›Feb 16, 2026device recall179d agoMedline Industries, LP device recall (Cls II)

    THORACIC ROBOTS, DYNJ908777B — Reason: Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure. — Status: Ongoing

    full page →fda device recalls ↗
    ← prev
    page 1 of 4
    next →
    $MMSI90.50-0.77%
    $MMSI90.50-0.77%
    $MMSI90.50-0.77%
    $MMSI90.50-0.77%
    $MMSI90.50-0.77%
    $LMAT81.93-0.24%
    $BSX51.69+0.53%